EZH2 and cervical carcinoma: Azizmohammadi et al. also studied different FIGO stages of cervical cancer including 22 cases (56%) of stage IB-IIA cancer and 17 cases (44%) of stage IIB-IIIA cancer and found statistically significant correlation (p < 0.05) between EZH2 expression and increasing FIGO stages [24].